Mark Cuban's bombshell AI warning is a reality check for big tech
Embedding advertisements inside AI-generated responses creates scalable manipulation risks and separates companies into those proficient at AI and those that are not.
After the FDA crackdown, here's how some companies are still selling GLP-1s
Microdosing now commonly refers to low-dose GLP-1 weight-loss medications sold via compounded formulations and telehealth, raising safety and regulatory concerns.
'Europe is not the US': Tech insiders call for smarter AI rules
"This is a big, sophisticated technology, and we want to get it right. We need specific obligations to capture some of the most impactful or potentially harmful models under the AI Act."